Analysis of recommended usage, dosage and dosing frequency of Omalizumab

Omalizumab (Omalizumab) is an injectable humanized monoclonal antibody, mainly used to treat moderate to severe allergic asthma and chronic spontaneous urticaria that are ineffective with traditional antihistamine drugs. During use, the dosage and administration frequency of the drug need to be individually adjusted according to different indications, patient weight, allergen IgE level and other factors, so injections must be performed under the guidance of a professional doctor.

For patients with asthma, omalizumab dosing is usually based on the patient's weight (range 20–150kg) and serum totalIgE levels (30–700 IU/mL) to determine. The common dosage is once every 2 weeks or every 4 weeks, with each injection dose ranging from 75mg to 375mg. For example, patients who are heavier and have higher IgE levels may need higher doses and more frequent injections. The injection is subcutaneous and is usually given by a professional in a hospital or outpatient setting.

For patients with chronic spontaneous urticaria, the recommended dose is relatively fixed. Injections of 150 mg or 300 mg every 4 weeks are generally recommended, without adjustment based on IgE levels or body weight. This dosage regimen has been adopted by many international guidelines and has been proven to effectively relieve urticaria symptoms in most patients and significantly reduce skin itching and the number of wheal attacks. In some stubborn cases, extending or shortening the dosing cycle may be considered after physician evaluation.

It is worth emphasizing that the onset of effect of omalizumab is usually several weeks after taking the drug, so patients should patiently observe the effect and should not stop the drug or change the dose at will because there is no obvious improvement in the early stage. During the medication period, the treatment response should be reviewed regularly to evaluate the treatment response, and a decision should be made whether to continue the treatment or gradually reduce the dose according to changes in the condition. To ensure maximum safety and efficacy, be sure to use it under the guidance of a doctor and avoid adjusting the injection frequency or dosage on your own.

Reference materials:https://www.drugs.com/